Reactivation of Hepatitis B in a Patient Coinfected with Hiv/Hbv Undergoing Therapy Without the use of Tenofovir: A Case Report
Article Information
Publication Timeline
- Published
Abstract
Coinfection with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) is a significant clinical challenge, especially during changes in antiretroviral therapy. Tenofovir is a key drug for the simultaneous suppression of HIV and HBV, and its suspension can lead to HBV reactivation in individuals with latent or occult infection. This study reports a case of hepatitis B reactivation after tenofovir withdrawal. The patient was a 68-year-old male diagnosed with HIV in 1985, on antiretroviral therapy since 1998, and with an undetectable HIV viral load for several years. In February 2024, tenofovir disoproxil fumarate was discontinued due to renal changes and osteopenia. Three months after withdrawal, the patient presented with a significant elevation of liver transaminases. Initially, drug-induced hepatotoxicity was considered; however, investigation revealed HBsAg, total anti-HBc, and HBeAg reactants, in addition to an HBV viral load of 16,100,000 copies, confirming viral reactivation. The introduction of tenofovir alafenamide resulted in a progressive reduction in HBV viral load and laboratory improvement. The case highlights the need for complete serological evaluation for hepatitis B before changes in the antiretroviral regimen and the risk associated with inadvertent suspension of tenofovir in coinfected patients.
References
- World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery, and monitoring. Geneva: World Health Organization; 2021. [Google Scholar][Crossref]
- Brazil. Ministry of Health. Secretariat of Science, Technology, Innovation, and Health Complex. Secretariat of Health and Environmental Surveillance. Clinical protocol and therapeutic guidelines for hepatitis B and coinfections. 1st ed. Brasília: Ministry of Health; 2023. [Google Scholar][Crossref]
- Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2009;49(Suppl 5):S138– S145. doi:10.1002/hep.22883. [Google Scholar][Crossref]
- Cheng Z, Lin P, Cheng N. HBV/HIV coinfection: impact on the development and clinical treatment of liver diseases. Front Med. 2021;8:713981. doi:10.3389/fmed.2021.713981. [Google Scholar][Crossref]
- Fasano M, et al. Management of chronic hepatitis B in HIV-coinfected patients. Viruses. 2022;14(9):2022. doi:10.3390/v14092022. [Google Scholar][Crossref]
- Gupta A, et al. Prevention and management of hepatitis B virus infection in adults with HIV. Baltimore: Johns Hopkins University; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK584516/ [Google Scholar][Crossref]
- Malagnino V, et al. Role of HBcAb positivity in increase of HIV-RNA detectability after switching to a two-drug regimen lamivudine-based treatment. Viruses. 2023;15(1):193. doi:10.3390/v15010193. [Google Scholar][Crossref]
- Salpini R, et al. Kinetics of hepatitis B virus replication in anti-HBc positive people with HIV switching to tenofovir-sparing therapy. Int J Infect Dis. 2025;150:107294. doi:10.1016/j.ijid.2024.107294. [Google Scholar][Crossref]
- Mican R, et al. Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient. AIDS. 2021;35(10):1707–1708. doi:10.1097/QAD.0000000000002941. [Google Scholar][Crossref]
- Toka B, et al. Comparison of tenofovir disoproxil fumarate and entecavir in the prophylaxis of HBV reactivation. Dig Dis Sci. 2021;66(7):2417–2426. doi:10.1007/s10620-020-06506-w. [Google Scholar][Crossref]
- Corcorran MA, Kim HN. Chronic hepatitis B and HIV coinfection. Top Antivir Med. 2023;31(1):14–22. [Google Scholar][Crossref]
- Brazil. Ministry of Health. Secretariat of Science, Technology, Innovation, and Health Complex. Secretariat of Health Surveillance and Environment. Clinical protocol and therapeutic guidelines for the management of HIV infection in adults: Module 2 – Coinfections and opportunistic infections. Brasília: Ministry of Health; 2024. [Google Scholar][Crossref]
- Singh KP, et al. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS. 2017;31(15):2035–2052. doi:10.1097/QAD.0000000000001574. [Google Scholar][Crossref]
- Moretto F, et al. Isolated anti-HBc: significance and management. J Clin Med. 2020;9(1):202. doi:10.3390/jcm9010202. [Google Scholar][Crossref]
- Weissmann L. Plasma detection of viral DNA in individuals with chronic hepatitis B virus infection coinfected with HIV [thesis]. São Paulo: University of São Paulo; 2020. [Google Scholar][Crossref]
- Souza DAC, et al. Characterization of HIV and hepatitis B coinfection in the population of a referral hospital in São Luís-MA. São Luís; 2023. [Google Scholar][Crossref]
- Abdullahi A, et al. Hepatitis B virus infection and reactivation during nucleos(t)ide reverse transcriptase inhibitor-sparing antiretroviral therapy in a high-HBV endemicity setting. Open Forum Infect Dis. 2018;5(10):ofy251. doi:10.1093/ofid/ofy251. [Google Scholar][Crossref]
- Mohareb AM, et al. Virological and serological outcomes in people with HIV-HBV coinfection who discontinued tenofovir therapy. J Virus Erad. International Journal of Medical and All Body Health Research www.allmedicaljournal.com 2024;10(4):100574. doi:10.1016/j.jve.2024.100574. [Google Scholar][Crossref]
- Salpini R, et al. Cryptic HBV replicative activity revealed in anti-HBc-positive/HBsAg-negative patients with HIV. Microorganisms. 2020;8(11):1819. doi:10.3390/microorganisms8111819. [Google Scholar][Crossref]
- Myint A, Tong MJ, Beaven SW. Reactivation of hepatitis B virus: a review of clinical guidelines. Clin Liver Dis. 2020;15(4):162–167. [Google Scholar][Crossref]
- Brazil. Ministry of Health. Department of HIV/AIDS, Tuberculosis, Viral Hepatitis, and STIs. Secretariat of Health Surveillance and Environment. Epidemiological Bulletin on Viral Hepatitis. Special issue. Brasília: Ministry of Health; 2025. [Google Scholar][Crossref]
- Mohareb AM, et al. Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B. Lancet HIV. 2022;9(8):e585–e594. [Google Scholar][Crossref]
- Begré L, et al. Circulating HBV RNA and hepatitis B core–related antigen trajectories in persons with HIV/HBV coinfection and hepatitis B surface antigen loss during tenofovir therapy. J Infect Dis. 2024;230(4):e954–e963. doi:10.1093/infdis/jiae189. [Google Scholar][Crossref]
- Corcorran MA, Kim HN. Strategies for hepatitis B virus prevention in people living with HIV. Curr HIV/AIDS Rep. 2023;20(6):451–457. doi:10.1007/s11904-023-00658-9. [Google Scholar][Crossref]
- Uzun T. Prolonged cholestatic hepatitis B as the initial presentation of HIV coinfection: a case report. Hepat Mon. 2025;25(1):e165783. doi:10.5812/hepatmon-165783. [Google Scholar][Crossref]
- Coffin CS, et al. Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus/human immunodeficiency virus co-infected patients. J Clin Virol. 2013;57(2):103–108. doi:10.1016/j.jcv.2013.01.016. [Google Scholar][Crossref]
- Chen S, et al. HBsAg loss in HIV/HBV coinfected patients: hepatitis B cure insights and implications. Infect Dis Immun. 2025;5(4):249 –259. doi:10.1097/ID9.0000000000000174. [Google Scholar][Crossref]
- Hawkins C, et al. Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy. AIDS. 2022;36(7):975–984. doi:10.1097/QAD.0000000000003193. [Google Scholar][Crossref]
- Ma H, et al. Overview of the immunological mechanisms in hepatitis B virus reactivation: implications for disease progression and management strategies. World J Gastroenterol. 2024;30(10):1295. doi:10.3748/wjg.v30.i10.1295. [Google Scholar][Crossref]
- Dossaji Z, et al. A review of hepatitis B reactivation risk on immunosuppressants with a focus on newer immunomodulators. Curr Hepatol Rep. 2024;23(2):253– 267. doi:10.1007/s11901-024-00662-7. [Google Scholar][Crossref]
- Bittencourt JASS, et al. Contribution to the study of chronic liver disease in HIV-infected patients. Rio de Janeiro: Rio de Janeiro State University; 2021. Available from: http://www.bdtd.uerj.br/handle/1/22232 [Google Scholar][Crossref]
How to Cite
Senise, B. L., & Bezerra, T. A. R. (2026). Reactivation of Hepatitis B in a Patient Coinfected with Hiv/Hbv Undergoing Therapy Without the use of Tenofovir: A Case Report. International Journal of Medical and All Body Health Research, 7(1), 176-180. https://doi.org/10.54660/IJMBHR.2026.7.1.176-180
Senise, Bruna Lourenço, and Thiago Augusto Rochetti Bezerra. "Reactivation of Hepatitis B in a Patient Coinfected with Hiv/Hbv Undergoing Therapy Without the use of Tenofovir: A Case Report." International Journal of Medical and All Body Health Research, vol. 7, no. 1, 2026, pp. 176-180. https://doi.org/10.54660/IJMBHR.2026.7.1.176-180.
Senise, B. L. and Bezerra, T. A. R. (2026) 'Reactivation of Hepatitis B in a Patient Coinfected with Hiv/Hbv Undergoing Therapy Without the use of Tenofovir: A Case Report', International Journal of Medical and All Body Health Research, 7(1), pp. 176-180. doi: 10.54660/IJMBHR.2026.7.1.176-180.
Senise BL, Bezerra TAR. Reactivation of Hepatitis B in a Patient Coinfected with Hiv/Hbv Undergoing Therapy Without the use of Tenofovir: A Case Report. International Journal of Medical and All Body Health Research. 2026;7(1):176-180. doi:10.54660/IJMBHR.2026.7.1.176-180
Similar Articles
- Study of Serological Markers of Parenterally Transmitted Viral Infections (Hepatitis B and C) in Acute Suspected Hepatitis Vol 7, Issue 3 (2026)
- The immunological evaluate of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) co-infection with plasmodium in Wukari, Taraba State, North East, Nigeria Vol 4, Issue 2 (2023)
- Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Co-Infections among Patients attending General Hospital, Wukari, Taraba State, North East, Nigeria Vol 4, Issue 2 (2023)
- Dacryops or Lacrimal Gland Cyst – A Rare Case Report Vol 7, Issue 1 (2026)
- Pterygium Excision with Conjunctival Flap Transposition and Intraoperative Mitomycin C Adjunctive Therapy Vol 7, Issue 1 (2026)
Find this Article on
Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASEA newly published article may take a few days to appear on these services.